#FDAApproval
Exciting news! Formosa Pharmaceuticals, Inc. (6838.TWO) has received FDA approval for their hashtag#ophthalmic eye drops, APP13007, which are used to treat post-operative inflammation and pain following eye surgery. This approval is a major milestone for Formosa Pharmaceuticals as they work towards launching their product in the US market, in partnership with Eyenovia, Inc., by mid-year. Congratulations to Formosa Pharmaceuticals and its CEO Erick Co (許力克) on this achievement! 

Read more about this groundbreaking achievement: https://lnkd.in/gJBSVNH7

Stay tuned with hashtag#Globalbio for more updates on pharmaceutical innovations!